[Stormorken's syndrome]

Area of Science:

• Hematology
• Genetics
• Neurology

Context:

• A complex syndrome characterized by thrombopathia, thrombopenia, asplenia, miosis, headache, ichthyosis, dyslexia, muscle defect, and hypocalcemia was first described in 1985.
• Key patient concerns include skin and deep bleeding, leg spasms, disturbed dark vision, and dyslexia.
• This paper presents a review of investigations performed on patients with this syndrome.

Purpose:

• To describe patients presenting with this rare syndrome.
• To review the investigations conducted to understand the syndrome's multifaceted characteristics.
• To explore potential causes and contributing factors for the observed clinical manifestations.

Summary:

• The bleeding tendency is attributed to complex platelet membrane disturbances affecting hemostatic plug stability, with the exact mechanism of membrane scrambling unresolved.
• Muscle defects involve tubular aggregates and elevated creatine kinase levels, potentially linked to hypocalcemia, as calcitriol treatment improves muscle function.
• Miosis causes decreased dark vision and may contribute to dyslexia; asplenia has minimal impact on immunocompetence, with patients surviving extensive periods without critical infections.

Impact:

• Provides a comprehensive overview of a rare syndrome, aiding in diagnosis and understanding.
• Highlights the complex interplay between platelet function, muscle physiology, and neurological symptoms.
• Identifies potential therapeutic avenues, such as calcium supplementation for muscle function, while emphasizing the unresolved genetic basis.